RU2022129311A - METHOD FOR PRODUCING TWO 4-{[(2S)-2-{4-[5-CHLORO-2-(1H-1,2,3-TRIAZOL-1-YL)PHENYL]-5-METHOXY-2-OXOPYRIDIN-1 (2H)-IL} BUTANOYL]AMINO}-2-FLUOROBENZAMIDE DERIVATIVES - Google Patents

METHOD FOR PRODUCING TWO 4-{[(2S)-2-{4-[5-CHLORO-2-(1H-1,2,3-TRIAZOL-1-YL)PHENYL]-5-METHOXY-2-OXOPYRIDIN-1 (2H)-IL} BUTANOYL]AMINO}-2-FLUOROBENZAMIDE DERIVATIVES Download PDF

Info

Publication number
RU2022129311A
RU2022129311A RU2022129311A RU2022129311A RU2022129311A RU 2022129311 A RU2022129311 A RU 2022129311A RU 2022129311 A RU2022129311 A RU 2022129311A RU 2022129311 A RU2022129311 A RU 2022129311A RU 2022129311 A RU2022129311 A RU 2022129311A
Authority
RU
Russia
Prior art keywords
oxopyridin
butanoyl
triazol
chloro
methoxy
Prior art date
Application number
RU2022129311A
Other languages
Russian (ru)
Inventor
Юлиан ЭГГЕР
Даниель ГЁТЦ
Михаль ЗОВА
Original Assignee
Байер Акциенгезельшафт
Байер Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Акциенгезельшафт, Байер Фарма Акциенгезельшафт filed Critical Байер Акциенгезельшафт
Publication of RU2022129311A publication Critical patent/RU2022129311A/en

Links

Claims (5)

1. 4-({(2S)-2-[4-{5-Хлор-2-[4-(трифторметил)-1H-1,2,3-триазол-1-ил]фенил}-5-метокси-2-оксопиридин-1(2H)-ил]бутаноил}-амино)-2-фторбензамид ацетон, имеющий формулу1. 4-({(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy- 2-oxopyridin-1(2H)-yl]butanoyl}-amino)-2-fluorobenzamide acetone having the formula
Figure 00000001
Figure 00000001
 2. Способ получения 4-({(2S)-2-[4-{5-хлор-2-[4-(трифторметил)-1H-1,2,3-триазол-1-ил]фенил}-5-метокси-2-оксопиридин-1(2H)-ил]бутаноил}-амино)-2-фторбензамида (II), имеющего формулу (II)2. Method for obtaining 4-({(2S)-2-[4-{5-chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5- methoxy-2-oxopyridin-1(2H)-yl]butanoyl}-amino)-2-fluorobenzamide (II) having the formula (II)
Figure 00000002
Figure 00000002
 отличающийся тем, что 4-({(2S)-2-[4-{5-хлор-2-[4-(трифторметил)-1H-1,2,3-триазол-1-ил]фенил}-5-метокси-2-оксопиридин-1(2H)-ил]бутаноил}-амино)-2-фторбензамид ацетон (IIc) изолируют и превращают в 4-({(2S)-2-[4-{5-хлор-2-[4-(трифторметил)-1H-1,2,3-триазол-1-ил]фенил}-5-метокси-2-оксопиридин-1(2H)-ил]бутаноил}-амино)-2-фторбензамид (II).characterized in that 4-({(2S)-2-[4-{5-chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5- methoxy-2-oxopyridin-1(2H)-yl]butanoyl}-amino)-2-fluorobenzamide acetone (IIc) is isolated and converted to 4-({(2S)-2-[4-{5-chloro-2- [4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}-amino)-2-fluorobenzamide (II ).
RU2022129311A 2018-03-15 2019-03-08 METHOD FOR PRODUCING TWO 4-{[(2S)-2-{4-[5-CHLORO-2-(1H-1,2,3-TRIAZOL-1-YL)PHENYL]-5-METHOXY-2-OXOPYRIDIN-1 (2H)-IL} BUTANOYL]AMINO}-2-FLUOROBENZAMIDE DERIVATIVES RU2022129311A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18161983.4 2018-03-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2020133706A Division RU2804663C2 (en) 2018-03-15 2019-03-08 Method of producing two 4-{[(2s)-2-{4-[5-chloro-2-(1h-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2h)-il} butanoyl]amino}-2-fluorobenzamide derivatives

Publications (1)

Publication Number Publication Date
RU2022129311A true RU2022129311A (en) 2022-12-02

Family

ID=

Similar Documents

Publication Publication Date Title
CL2020002371A1 (en) Preparation process of two derivatives of 4 - {[(2s) -2- {4- [5-chloro-2- (1h-1,2,3-triazol-1-yl) phenyl] -5-methoxy-2 -oxpyridin-1 (2h) -yl} butanoyl] amino} -2-fluorobenzamide
CA2542909A1 (en) 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
IL281191A (en) Salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylate and preparation process thereof
MA34552B1 (en) CRYSTALLINE (R) - (E) -2- (4- (2- (5- (1- (3,5-DICHLOROPYRIDIN-4-yl) ETHOXY) -1H-INDAZOL-3-YL) VINYL) -1H - PYRAZOL-1-YL) ANDHANOL AND ITS USE AS FGFR INHIBITOR
GB201609607D0 (en) Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
FI2440547T3 (en) New chemical molecules that inhibit the splicing mechanism for the treatment of diseases resulting from splicing defects
NZ599778A (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
AR111469A1 (en) COME OUT OF AN AMINOPIRIDINE DERIVATIVE COMPOUND, A CRYSTAL FORM OF THE SAME, AND A PROCESS TO PREPARE THE SAME
NZ611865A (en) Pyrazole derivative
MX338024B (en) Optically active dibenzylamine derivative, and manufacturing method for same.
PE20161236A1 (en) TRIAZINE COMPOUND AND ITS USE FOR MEDICAL PURPOSES
RU2017145929A (en) ROR GAMMA MODULATORS (RORγ)
MX2019008171A (en) Inhibitors of nhe-mediated antiport.
PH12019500252A1 (en) Compound for use in the treatment of neurogenic orthostatic hypotension
RU2022129311A (en) METHOD FOR PRODUCING TWO 4-{[(2S)-2-{4-[5-CHLORO-2-(1H-1,2,3-TRIAZOL-1-YL)PHENYL]-5-METHOXY-2-OXOPYRIDIN-1 (2H)-IL} BUTANOYL]AMINO}-2-FLUOROBENZAMIDE DERIVATIVES
ES2421587T3 (en) Use of pyrimidylaminobenzamide derivatives for the treatment of systemic mastocytosis
RU2007147957A (en) The combination of pyrimidylamino-benzamide derivatives and imatinib for the treatment or prevention of proliferative diseases
CY1120933T1 (en) CRYSTAL OF BENZOLIE PRODUCER AZOL AS XANTHIN OXIDATION INHIBITOR
TR201902314T4 (en) Azole benzene derivative and its crystal.
RU2016149494A (en) 2- (4-Methoxyphenylamino) -4- (2,4-dimethylphenyl) -1- (piperazin-1-yl) but-2-en-1,4-dione hydrochloride having hemostatic activity
MX2020007177A (en) Crystals.
BRPI0517083A (en) 4- (4-methylpiperazin-1-ylmethyl) -n- {4-methyl-3- (4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl} -benzamide to inhibit the c-fms receptor of tyrosine kinase
DE602004022540D1 (en) USE OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF DIABETES
AR114231A2 (en) HETEROCYCLIC AMIDE COMPOSITION, INCLUDING PHARMACEUTICAL COMPOSITION AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
MX2018009742A (en) Pharmaceutical composition containing imidazoline derivative.